Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Spinning To Be Agile: GE Healthcare’s Precision Health Ambition Majors On Lean

With Its Upcoming Separation GE Healthcare Proclaims Move From Traditional Imaging To Therapy And Surgery Solutions

Executive Summary

Incoming president and CEO Peter Arduini laid out a path towards an agile future that exploits the ‘power of lean’ for GE Healthcare, ahead of the division’s 2023 spin off as a separate company.

You may also be interested in...



HIMSS 2022: GE Introduces Edison Platform To Integrate Clinical Data From Multiple Sources

The Edison Digital Health Platform is a “vendor-agnostic” platform with an integrated AI engine that will allow health care systems to aggregate data from connect devices and other sources.

Ukraine Wants Medtech Business As Usual Even As Russian Siege Intensifies

The medtech supply chain is damaged and humanitarian aid needs are rising after two weeks of the Russian military invasion of Ukraine. The government is addressing the emergency situation while driving to maintain business as usual for the sake of the economy.

GE Healthcare Expands Into Intraoperative Ultrasound By Acquiring BK Medical For $1.45Bn

BK Medical’s intraoperative imaging and surgical navigation technologies will help GE Healthcare’s ultrasound business expand outside diagnostic imaging into surgical and therapeutic interventions.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

IV125035

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel